查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009331

奈米孔技术市场规模、份额、趋势和预测：按产品、应用、最终用户和地区划分，2026-2034年

Nanopore Technologies Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2025年全球奈米孔技术市场规模为3.418亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到8.348亿美元，2026年至2034年的复合年增长率（CAGR）为10.12%。目前，北美市场主导地位，预计2025年市占率将超过41.2%。全球市场成长的主要驱动因素包括：对精准医疗和即时、经济高效的DNA/RNA定序的需求不断增长；在诊断和药物研发领域的应用日益广泛；定序准确性和便携性的提高；研发投入的增加；以及在基因组学、蛋白质组学和个人化医疗解决方案领域的应用日益普及。

由于奈米孔技术能够实现DNA和RNA的即时、低成本定序，全球市场的主要驱动力是精准医疗和基因分析需求的不断增长。此外，该技术在诊断工具、药物研发和个人化医疗等领域的应用不断拓展，也推动了市场成长。定序准确性的持续提升、成本的降低以及通量能力的提高，进一步提振了奈米孔技术市场的前景。同时，对快速便携式诊断方法日益增长的需求，以及基因组学和蛋白​​质组学领域的持续研究，加上不断增加的研发投入，共同促进了市场扩张。例如，2025年1月13日，Truveta宣布获得来自Regeneron Pharmaceuticals、Illumina和17家美国医疗机构的3.2亿美元投资，用于建立全球最大的基因资料库。该计画旨在收集1000万个基因组序列，以改善药物研发和患者照护。 Regeneron将投资1.2亿美元进行定序，Illumina将投资2,000万美元。该计画预计将透过纳入匿名化的医疗记录和经患者同意的检体，扩大规模和多样性。

美国作为重要的区域市场脱颖而出，这主要归因于癌症和心血管疾病等慢性病的日益普及。例如，根据美国食品药物管理局（FDA）的数据，美国十大死因中有七种是常见慢性病（CCD），其中与饮食相关的疾病，如心血管疾病、糖尿病、肥胖和某些癌症，占了相当大的比例。美国在饮食相关疾病的盛行率方面落后于42个国家，而且仍有2800万美国人吸烟，这增加了对独特治疗性介入的需求。微生物学和环境监测领域的研究活动日益增多，奈米孔装置被用于检测病原体和污染物。此外，人工智慧与奈米孔技术的融合正在提高数据分析和诊断的准确性。同时，医疗和农业领域对快速、高效和现场检测的需求也促进了市场成长。该国强大的医疗基础设施和政府对生物技术创新的有利支持，进一步加速了奈米孔技术的应用。

奈米孔技术市场的发展趋势：

临床应用领域的拓展

由于奈米孔定序能够即时定序长链DNA和RNA，因此在临床诊断领域正日益受到重视。其革命性的潜力体现在感染疾病诊断方面，能够加速病原体鑑定并显着改善患者预后。奈米孔技术在癌症基因组学领域的应用也日益广泛，能够分析结构变异、甲基化模式和基因融合等对制定个人化治疗策略至关重要的资讯。 2024年9月发表的一项研究探讨了牛津奈米定序在评估医院内感染疾病传播风险的应用，但并未提供使用该技术的医院数量数据。 2024年6月发表的另一项研究则着重于纽西兰一家四级医疗机构的奈米孔定序基准测试和品管，显示该技术正在特定医疗机构中得到应用。与传统定序相比，奈米孔技术无需扩增或大规模样本製备，因此在临床应用中效率更高。其多功能性和不断降低的成本正使奈米孔定序成为精准医疗的核心技术。该技术能够适应不断变化的医疗需求，例如疫情监测和抗生素抗药性管理，这进一步凸显了其革新临床应用和推动奈米孔技术市场持续成长的潜力。

携带式的进步

奈米孔技术正透过携带式定序设备的快速发展，彻底改变基因分析的便利性和可近性。牛津奈米孔公司的「MinION」定序仪因其小巧的体积、经济的价格以及即时交付定序结果的功能而广受欢迎。截至2023年，MinION设备已在全球100多个国家使用，展现了其卓越的全球普及度。由于这些行动装置，研究人员和医疗保健专业人员现在可以在各种环境下进行基因分析，包括偏远地区和资源匮乏的环境。这种便携性对于田间病原体监测、农业基因组学和环境监测等应用尤其重要，因为在这些应用中，在现场建立完整的实验室并不现实。此外，将行动装置与基于云端的分析平台集成，可增强其功能，并实现即时数据共用和协作。对开发用户友好且功能强大的设备的日益重视，正在使定序技术更加普及，并扩大奈米孔技术的市场份额。

加大基因组研究的投资

除了私人企业外，各国政府、学术机构和个人对基因组研究的投入不断增加，正在成长要素。最新数据显示，美国国立卫生研究院 (NIH) 已拨款高达 2700 万美元用于构建利用基因组分析的学习型医疗保健系统，其中第一年就累计540 万美元用于将基因组分析整合到患者照护中。这些措施表明，人们越来越关注利用奈米孔定序平台等先进定序技术来改善医疗效果。这些投资有望加深我们对遗传讯息本质及其对健康、农业和环境科学意义的理解。诸如人类基因组计划以及美国和中国等国家的国家基因组研究项目等资助倡议正在推动定序技术的创新，包括基于奈米孔的测序平台。私人企业也投入大量资源开发尖端的奈米孔定序设备，以满足对更快、更低成本、更精确的定序解决方案日益增长的需求。资金的涌入正在加速技术进步，并催生个人化医疗和合成生物学等领域的新应用。研究经费的稳定成长凸显了奈米孔技术在更广泛的基因组学生态系统中发挥的关键作用。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球奈米孔技术市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 装置
    • 主要部分
      • 可携式的
      • 工作檯面
  • 消耗品

第七章 市场区隔：依应用领域划分

  • DNA定序
  • RNA定序
  • 其他的

第八章 市场区隔：依最终用户划分

  • 医院和诊所
  • 研究机构
  • 其他的

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Agilent Technologies Inc.
    • Cyclomics BV
    • Electronic Biosciences Inc.
    • Inanobio Inc.
    • Nabsys Inc.
    • Ontera Inc.
    • Oxford Nanopore Technologies Limited
    • Pacific Biosciences of California Inc.
    • Quantapore Inc.
    • Roche Holding AG
    • Tracxn Technologies Limited
Product Code: SR112026A4718

The global nanopore technologies market size was valued at USD 341.8 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 834.8 Million by 2034, exhibiting a CAGR of 10.12% during 2026-2034. North America currently dominates the market, holding a significant market share of over 41.2 % in 2025. The global market is majorly driven by rising demand for precision medicine, real-time and cost-effective DNA/RNA sequencing, expanding applications in diagnostics and drug discovery, advancements in sequencing accuracy and portability, increasing research investments, and growing adoption in genomics, proteomics, and personalized healthcare solutions.

The global market is primarily driven by the increasing demand for precision medicine and genetic analysis as nanopore technology offers real-time, cost-effective sequencing of DNA and RNA. Moreover, the growing applications in diagnostic tools, drug discovery, and personalized medicine are fueling market growth. Additionally, ongoing advancements in sequencing accuracy, reduced costs, and improved throughput capabilities are further creating a positive nanopore technologies market outlook. Moreover, the rising need for rapid, portable diagnostics and the ongoing efforts in the fields of genomics and proteomics are also contributing to the market's expansion, along with increased research investments. For instance, on January 13, 2025, Truveta announced a USD 320 Million investment from Regeneron Pharmaceuticals, Illumina, and 17 U.S. health systems to create the world's largest genetic database. This initiative aims to compile 10 million genomic sequences, enhancing drug discovery and patient care. Regeneron will contribute USD 120 Million and conduct the sequencing, while Illumina will invest USD 20 Million. The project will extend this work in scale and diversity to include patient-consented, anonymized medical records and specimens.

The United States stands out as a key regional market, primarily driven by the prevalence of chronic diseases such as cancer and cardiovascular conditions is rising. For instance, U.S. Food & Drug Administration reported that seven of the ten major causes of death in the U.S. are common chronic diseases (CCDs), with diet-related illnesses such as cardiovascular disease, diabetes, obesity, and certain cancers contributing significantly. The U.S. ranks behind 42 countries in diet-related disease rates, and 28 million Americans continue to smoke, which is fueling the need for unique therapeutic intervention. increasing research activities in the areas of microbiology and environmental monitoring where nanopore devices are used for the detection of pathogens and contaminants. In addition, the integration of artificial intelligence with nanopore technology is improving the data analysis and the diagnostic accuracy. Furthermore, the healthcare and agricultural sector demands immediate, efficient, and on-site tests, which is contributing to market growth. The country's strong healthcare infrastructure and favorable government initiatives for the support of biotech innovations are accelerating the adoption of nanopore technologies further.

NANOPORE TECHNOLOGIES MARKET TRENDS:

Expanding Clinical Applications

Nanopore sequencing is increasingly becoming popular in clinical diagnostics as it has the capability to sequence long DNA or RNA strands in real-time. Its transformative power is in infectious disease diagnostics, where pathogen identification becomes faster and greatly improves patient outcome. Applications in cancer genomics are increasing as nanopore technologies enable the analysis of structural variants, methylation patterns, and gene fusions that are important for the formulation of personalized treatment strategies. A study published in September 2024 discusses the application of Oxford Nanopore sequencing to assess the possible transmission of infections within a hospital setting, but it does not provide data on the number of hospitals using the technology. Another study from June 2024 focuses on benchmarking and quality control for nanopore sequencing in a single quaternary hospital in New Zealand, indicating that the technology is being implemented in specific institutions. In contrast to conventional sequencing, nanopore technology does not require amplification or extensive sample preparation, making it very efficient for clinical use. Its versatility and declining costs are setting nanopore sequencing as a core technology in precision medicine. The adaptability of the technology to address emerging healthcare needs, such as monitoring pandemics and managing antimicrobial resistance, further emphasizes its potential to revolutionize clinical applications and drive sustained nanopore technologies market growth.

Advancements in Portable Devices

Nanopore technologies are revolutionizing the accessibility and usability of genetic analysis through rapid developments in portable sequencing devices. The Oxford Nanopore's MinION has been popular in its compact form, affordability, and real-time delivery of sequencing results. As of 2023, the MinION device has been used in over 100 countries, highlighting its global reach. Researchers and healthcare providers are empowered by these portable devices to conduct onsite genetic analyses within diverse environments- remote and resource limited. This portability is significantly beneficial in applications such as field-based pathogen surveillance, agricultural genomics, and environmental monitoring as it is impractical to set up a whole laboratory in the field. Besides that, the integration of cloud-based analysis platforms with portable devices tends to enhance their functionality, allowing real-time data sharing and collaboration. The increasing emphasis on the development of user-friendly and robust devices is democratizing access to sequencing technologies, expanding nanopore technologies market share.

Rising Investments in Genomic Research

Increasing investment by governments and academic institutions, in addition to private enterprises, into genomic research is a growth factor for the nanopore technologies market. According to recent data, the National Institutes of Health (NIH) has allocated up to USD 27 Million to establish genomics-enabled learning health systems and has earmarked USD 5.4 Million for the first year to integrate genomics into patient care. These initiatives underscore the growing emphasis on leveraging advanced sequencing technologies, such as nanopore platforms, for improving healthcare outcomes. These investments are expected to help better understand the nature of genetic information and what that might mean for health, agriculture, and environmental sciences. Funding initiatives such as the Human Genome Project and national genomic research programs in countries such as the U.S. and China are fueling innovation in sequencing technologies, including nanopore-based platforms. Private-sector players are also channeling significant resources into the development of cutting-edge nanopore devices to meet the rising demand for faster, cheaper, and more accurate sequencing solutions. This influx of funding is accelerating technological advancements and enabling new applications in personalized medicine, synthetic biology, and more. The steady growth in research funding underscores the pivotal role nanopore technologies play in the broader genomics ecosystem.

NANOPORE TECHNOLOGIES INDUSTRY SEGMENTATION:

Analysis by Product:

  • Instruments
    • Portable
    • Benchtop
  • Consumables

Consumables lead the market with around 55.0% of market share in 2025. The dominance of consumables in the nanopore technologies market is driven by the recurring demand for sequencing processes, such as flow cells, reagents, and sample preparation kits. These are essential components that ensure the performance and accuracy of nanopore devices, and thus, research institutions, healthcare providers, and diagnostic labs continue to purchase them. The growing need for personalized medicine and real-time sequencing applications ensures the sustained demand for consumables in the nanopore technologies market. Moreover, consumable design is being improved, with higher throughput flow cells and specialized reagents that are improving efficiency and lowering costs, which further increases adoption.

Analysis by Application:

  • DNA Sequencing
  • RNA Sequencing
  • Others

DNA sequencing leads the market with around 60.0% of market share in 2025. DNA sequencing plays a vital role in the nanopore technologies market as it gives real-time and long-read sequences that provide invaluable information about genetics. Moreover, the technology is cost-effective and portable for wide use in research and clinic settings, thereby making the nanopore market valuable. These are especially applied in the determination of complex variations, structural rearrangements, and epigenetic modifications. The growing demand for precision medicine and improvements in the speed and accuracy of sequencing will further support the application of this technology in the diagnosis of diseases, personalized treatment, and studies of evolution. Also, the greater integration of nanopore DNA sequencing in agriculture and microbiology strengthens its market leadership.

Analysis by End User:

  • Hospitals and Clinics
  • Research Institutes
  • Others

Research institutes lead the market with around 45.3% of market share in 2025. The market for nanopore technologies is dominated by research institutes due to the substantial contribution these institutes have toward genomic studies, molecular biology, and biotechnology. These institutes significantly apply nanopore sequencing to diverse applications such as genetic mutations, rare diseases, and the study of microbiomes. This nanopore platform's flexibility and scalability provide advanced research capabilities in areas such as transcriptomics and epigenetics. The development of grants and government funding for scientific research also increases adoption, together with cooperation by a large number of research institutes, which implements innovation through improved sequencing accuracy and efficiency, resulting in their dominant position in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 41.2% due to its superior healthcare infrastructure and substantial investments in biotechnology and genomic research. The region benefits from the presence of key industry players and has vast government funding for precision medicine and genomics. Furthermore, the acceptance of innovative technologies, including real-time sequencing and AI integration, is also speeding up the growth of the market. The demand from individualized medicines, diagnostics, agricultural, and environmental sectors forms further support for the market.

KEY REGIONAL TAKEAWAYS:

UNITED STATES NANOPORE TECHNOLOGIES MARKET ANALYSIS

In 2025, the US accounted for around 78.90% of the total North America nanopore technologies market. The U.S. nanopore technologies market is rising fast with immense investment in genomics and healthcare innovations. The NIH has granted up to USD 27 Million to create a network of genomics-enabled learning health systems and allocated USD 5.4 Million for the first year to embed genomics in patient care. All these efforts are enriching the application of nanopore-based sequencing in real-time clinical decision-making and disease management. Companies such as Oxford Nanopore Technologies are seizing the momentum with high-end, low-cost sequencing solutions. Market growth is driven by precision medicine and increased funding in genomic research. Through its collaborations with industries and the supportive role of the U.S. government towards innovative biotechnology activities, the United States is establishing its position as one of the global leaders in nanopore technologies.

EUROPE NANOPORE TECHNOLOGIES MARKET ANALYSIS

The nanopore technologies market in Europe is growing steadily with the rise in investments in genomic research and healthcare initiatives. Eurostat statistics revealed that the EU has set aside EUR 1.8 Billion (USD 1.9 Billion) in 2022 toward biotech innovation, most of which targets nanopore sequencing. The UK and Germany are the leaders, and institutions such as the Francis Crick Institute drive cutting-edge research. The adoption of nanopore technologies in next-generation sequencing is also on the rise in clinical diagnostics, especially in rare diseases. Moreover, personalized medicine has become a major emphasis in the EU, such as through Horizon Europe, further fostering nanopore technologies market demand. . With biotech growth being supported by regulatory frameworks, Europe will be an excellent player in the global market of nanopore technology.

ASIA PACIFIC NANOPORE TECHNOLOGIES MARKET ANALYSIS

The Asia Pacific nanopore technologies market is growing rapidly due to increased investments in genomics and healthcare advancement. Chinese nanopore sequencing company Qitan Tech raised a Series C round of RMB 700 Million (or about USD 103.7 Million) back in January 2023. This is significant private sector interest in the area. Countries such as China and India have focused heavily on genomic research and clinical applications, with initiatives such as "Make in India" enhancing domestic innovation in sequencing technologies. Further pushing market growth will be the increasing interest in personalized medicine and infectious disease detection in Japan and South Korea. Acceleration of innovation through collaborative partnerships between local and global players, increased government funding, and development of healthcare infrastructure are making the region a significant contributor to the global nanopore technologies market.

LATIN AMERICA NANOPORE TECHNOLOGIES MARKET ANALYSIS

Latin American nanopore technologies are growing with investments in genomics and biotechnology. For example, the National Fund for Scientific and Technological Development in Brazil was given more resources in the 2023 fiscal year according to Law No. 14.577 by Global Trade Alert. These resources support scientific research and innovation, including advancements in genomics. Countries such as Mexico and Colombia are also focusing on genomic research for regional health challenges, which is propelling the demand for innovative sequencing technologies. Private investments along with government initiatives are encouraging the collaboration of local researchers with international players, which will fuel the market growth. Further, the developing healthcare infrastructure along with the increased focus on precision medicine is emerging Latin America as a new hub in the global nanopore technologies market.

MIDDLE EAST AND AFRICA NANOPORE TECHNOLOGIES MARKET ANALYSIS

Nanopore technologies market in the Middle East and Africa is picking up as more investment in healthcare innovation takes place. For instance, the UAE's federal budget for 2023 had AED 63.066 Billion, or about USD 17.17 Billion, allocated to total expenditures. Of that amount, AED 4.8 Billion, or about USD 1.31 Billion, was allocated to healthcare and community protection (Ministry of Finance). The Emirati Genome Program also focuses on the complete sequencing of the Emirati genome to improve personalized healthcare. All these programs indicate the heavy incorporation of cutting-edge genomic technology within the health sector. Collaboration with international biotech companies and increasing investment in sequencing technologies in precision medicine is driving growth in the market. Expanding health infrastructure and government-sponsored research programs put the region as a fast-growing contributor to the global landscape of nanopore technologies.

COMPETITIVE LANDSCAPE:

The market is characterized by the presence of numerous established players and emerging innovators striving to enhance sequencing technologies. Companies are heavily investing in research and development to improve accuracy, throughput, and affordability, fostering a dynamic environment of technological advancements. Strategic partnerships, licensing agreements, and collaborations with academic institutions are prevalent, facilitating innovation and expanding application areas. In addition, market participants are focusing on miniaturization and portability of devices, catering to the rising demand for point-of-care diagnostics and field-based testing solutions across various sectors. Notably, on November 5, 2024, Oxford Nanopore Technologies announced its partnership with UK health agencies to speed up pathogen screening across up to 30 NHS sites. The partnership will identify severe respiratory infections and recommend treatments within six hours of sample collection, thus bolstering early warning systems for pandemic threats. Oxford Nanopore's long-read sequencing technology will be used in the project to improve monitoring of emerging bacterial and viral threats and the spread of drug-resistant pathogens.

The report provides a comprehensive analysis of the competitive landscape in the nanopore technologies market with detailed profiles of all major companies, including:

  • Agilent Technologies Inc.
  • Cyclomics BV
  • Electronic Biosciences Inc.
  • Inanobio Inc.
  • Nabsys Inc.
  • Ontera Inc.
  • Oxford Nanopore Technologies Limited
  • Pacific Biosciences of California Inc.
  • Quantapore Inc.
  • Roche Holding AG
  • Tracxn Technologies Limited

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the nanopore technologies market?

2. What is the future outlook of nanopore technologies market?

3. What are the key factors driving the nanopore technologies market?

4. Which region accounts for the largest nanopore technologies market share?

5. Which are the leading companies in the global nanopore technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nanopore Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Portable
      • 6.1.2.2 Benchtop
    • 6.1.3 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 DNA Sequencing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 RNA Sequencing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Cyclomics BV
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Electronic Biosciences Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Inanobio Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Nabsys Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Ontera Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Oxford Nanopore Technologies Limited
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pacific Biosciences of California Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Quantapore Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Roche Holding AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Tracxn Technologies Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Nanopore Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Nanopore Technologies Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Nanopore Technologies Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Nanopore Technologies Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Nanopore Technologies Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Nanopore Technologies Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Nanopore Technologies (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Nanopore Technologies (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Nanopore Technologies (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Nanopore Technologies (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Nanopore Technologies (DNA Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Nanopore Technologies (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Nanopore Technologies (RNA Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Nanopore Technologies (RNA Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Nanopore Technologies (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Nanopore Technologies (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Nanopore Technologies (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Nanopore Technologies (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Nanopore Technologies (Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Nanopore Technologies (Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Nanopore Technologies (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Nanopore Technologies (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Nanopore Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Nanopore Technologies Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Nanopore Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Nanopore Technologies Industry: SWOT Analysis
  • Figure 74: Global: Nanopore Technologies Industry: Value Chain Analysis
  • Figure 75: Global: Nanopore Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nanopore Technologies Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Nanopore Technologies Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Nanopore Technologies Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Nanopore Technologies Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Nanopore Technologies Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Nanopore Technologies Market: Competitive Structure
  • Table 7: Global: Nanopore Technologies Market: Key Players